CCCC
Price
$1.84
Change
-$0.16 (-7.96%)
Updated
Feb 4, 02:30 PM (EDT)
Capitalization
195.28M
15 days until earnings call
Intraday BUY SELL Signals
VYGR
Price
$3.83
Change
-$0.08 (-2.05%)
Updated
Feb 4, 03:54 PM (EDT)
Capitalization
217.12M
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CCCC vs VYGR

Header iconCCCC vs VYGR Comparison
Open Charts CCCC vs VYGRBanner chart's image
C4 Therapeutics
Price$1.84
Change-$0.16 (-7.96%)
Volume$100
Capitalization195.28M
Voyager Therapeutics
Price$3.83
Change-$0.08 (-2.05%)
Volume$200
Capitalization217.12M
CCCC vs VYGR Comparison Chart in %
CCCC
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CCCC vs. VYGR commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (CCCC: $2.01 vs. VYGR: $3.91)
Brand notoriety: CCCC and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 81% vs. VYGR: 82%
Market capitalization -- CCCC: $195.28M vs. VYGR: $217.12M
CCCC [@Biotechnology] is valued at $195.28M. VYGR’s [@Biotechnology] market capitalization is $217.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than CCCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 5 bullish TA indicator(s).

  • CCCC’s TA Score: 4 bullish, 4 bearish.
  • VYGR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а -6.07% price change this week, while VYGR (@Biotechnology) price change was -0.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

CCCC is expected to report earnings on Feb 19, 2026.

VYGR is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($217M) has a higher market cap than CCCC($195M). CCCC YTD gains are higher at: 5.236 vs. VYGR (-0.509). CCCC has higher annual earnings (EBITDA): -105.05M vs. VYGR (-136.19M). CCCC has more cash in the bank: 192M vs. VYGR (45.1M). VYGR has less debt than CCCC: VYGR (38.4M) vs CCCC (61.5M). VYGR (31.3M) and CCCC (30.1M) have equivalent revenues.
CCCCVYGRCCCC / VYGR
Capitalization195M217M90%
EBITDA-105.05M-136.19M77%
Gain YTD5.236-0.509-1,029%
P/E RatioN/A6.00-
Revenue30.1M31.3M96%
Total Cash192M45.1M426%
Total Debt61.5M38.4M160%
FUNDAMENTALS RATINGS
VYGR: Fundamental Ratings
VYGR
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCVYGR
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 22 days ago
83%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 16 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPTP13.500.01
+0.07%
Capital Properties, Inc.
LDSVF14539.44N/A
N/A
Lindt & Sprungli AG
SMDPY11.45N/A
N/A
Sumitomo Pharma Co Ltd.
IRCUF7.25-0.23
-3.08%
Irish Continental Group Plc
WCFB6.10-0.36
-5.57%
WCF Bancorp, Inc.

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with BEAM. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
+6.91%
BEAM - CCCC
43%
Loosely correlated
-0.11%
XNCR - CCCC
41%
Loosely correlated
-0.99%
SYRE - CCCC
40%
Loosely correlated
+1.65%
AXON - CCCC
40%
Loosely correlated
-1.89%
VYGR - CCCC
39%
Loosely correlated
-2.25%
More